Lyniate

United States · www.lyniate.com · 14 vendors

Resilience scores

Technology vendors

Services catalogue

1 service in catalogue across 1 category; runs on 14 sub-vendors.

Insights

Last updated 2026-07-09 · revision 3

14 direct vendors, 227 subvendors

Direct vendors by controlling owner country (sample)

Subvendors by controlling owner country (sample)

Migration Readiness: 9/10

Assessed by AI based on technology stack characteristics (cloud-native vs legacy, containerization, microservices), regulatory environment, data residency requirements, financial stability, and vendor lock-in risks. The score ranges from 0-10, where higher scores indicate better readiness for technology migration.

Lyniate exhibits very high migration readiness, scoring 90 out of 100. A major strength is the company's highly conducive internal tech stack for migration, featuring major cloud providers (Amazon Web Services, Microsoft Azure) and containerization technologies (Docker, Kubernetes). This indicates a strong foundation for adopting cloud-native architectures, microservices, and efficient workload portability. The data explicitly states "Total Vendors: 0," which is a significant advantage. This implies minimal to no external vendor lock-in, contract complexities, or dependencies that would typically impede migration efforts. The presence of 17 services from various geographic origins (4 unique countries) suggests a distributed service landscape without formal vendor ties, further simplifying migration. Additionally, data residency requirements are "Not specified," which, in the absence of explicit constraints, simplifies the planning and execution of data migration across different environments. Weaknesses and unknowns include the lack of data on revenue concentration and growth history, preventing an assessment of Lyniate's financial capacity to fund a significant migration initiative. Information on the regulatory environment is also not provided, and specific compliance requirements could introduce complexities and additional costs to migration planning and execution.

Financials

Three-year financials

Financial Resilience Score: 7/10

Lyniate demonstrates qualitative signs of financial resilience despite the absence of publicly disclosed financials. The company operates a recurring revenue model built on mission-critical middleware (Rhapsody and Corepoint integration engines) that is deeply embedded in hospital IT infrastructure, generating sticky subscription and maintenance revenue. Its customer base of 1,000+ healthcare organizations across 36+ countries provides diversification and reduces single-customer dependency. The company benefits from strong sponsorship by top-tier software-focused private equity firms, initially Thoma Bravo and then Hg Capital (as of October 2022), both of which provide capital access and operational discipline. Structural tailwinds from healthcare interoperability mandates (US 21st Century Cures Act, FHIR adoption, EU EHDS) support long-term demand growth. However, resilience is constrained by opacity: no audited financials, EBIT, leverage, or equity figures are publicly available. PE-owned businesses of this profile typically carry significant acquisition-related debt, and Lyniate has undergone two PE transactions plus multiple acquisitions requiring integration. Competition from InterSystems, Redox, Infor Cloverleaf, and EHR-native tools, combined with the 2023 brand transition to Rhapsody, adds execution risk.

Key strengths: Recurring subscription/maintenance revenue from mission-critical interoperability middleware, Diversified customer base of 1,000+ healthcare organizations across 36+ countries, Top-tier KLAS Research rankings (Corepoint repeatedly Best in KLAS for integration engines), Strong PE sponsorship (Thoma Bravo, then Hg Capital), Structural tailwinds from healthcare interoperability mandates (Cures Act, FHIR, EHDS)

Risk factors: Undisclosed but likely significant PE acquisition-related leverage, Integration risk from Corepoint+Rhapsody merger and NextGate acquisition, Competition from InterSystems, Redox, Infor Cloverleaf, and EHR-native tools, Very limited financial transparency as a private entity, Brand transition risk from retiring Lyniate name in favor of Rhapsody in 2023

Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.

View the full interactive report